Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools



Rating:

Share or cite this content

Citations should be made in the following way:
P. Montuschi, G. Ciabattoni, P. J. Barnes, V. Lucidi (Rome, Chieti, Italy; London, United Kingdom). Exhaled 8-isoprostane and prostaglandin E₂ in patients with stable and unstable cystic firbrosis. Eur Respir J 2008; 32: Suppl. 52, 2864

Member's Comments

No comment yet.

Related content which might interest you: Thromboxane B2 and prostaglandin E2 concentrations in exhaled breath condensate in healthy volunteers and patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002 Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007 Prostaglandin E2 in the expired breath condensate of patients with asthma Source: Eur Respir J 2003; 22: 743-747 Year: 2003 The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 181s Year: 2001 Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018 Year: 2019 Exhaled breath condensate: 8-isoprostane and eicosanoids Source: Eur Respir Monogr 2010; 49: 196-206 Year: 2010 Sputum neutrophilia is correlated with levels of exhaled nitric oxide (NO) in patients with chronic, stable sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 344s Year: 2001 Increased exhaled cysteinyl-leukotrienes, leukotriene B4 and 8-isoprostane in exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Exhaled 8-isoprostane as a marker of airway inflammation in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 39s Year: 2001 Exhaled breath condensate pH and exhaled nitric oxide in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 18s Year: 2003 Nitric oxide metabolites (NOx) in exhaled breath condensate as a non-invasive marker of airway inflammation in infants with cystic fibrosis. Comparisons with bronchoalveolar lavage findings Source: Eur Respir J 2004; 24: Suppl. 48, 157s Year: 2004 Prostaglandin E2 in the expired breath condensate of asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 165s Year: 2001 Elevated exhaled nitric oxide without acidification of exhaled breath condensate in patients with mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 506s Year: 2002 Exhaled nitric oxide and inhaled steroids in patients with stable asthma in primary care Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Orally and nasally exhaled nitric oxide and nitrite in asthmatic and cystic fibrosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 131s Year: 2003 Nitrite/nitrate levels in exhaled breath condensate are increased but exhaled nitric oxide levels were not in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006 Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Urinary leukotriene E4 and exhaled nitric oxide on recovery from exercise-induced bronchospasm in asthmatic children Source: Eur Respir J 2006; 28: Suppl. 50, 259s Year: 2006